4//SEC Filing
O'Brien Ronan 4
Accession 0001062993-23-001035
CIK 0001835567other
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 5:01 PM ET
Size
6.8 KB
Accession
0001062993-23-001035
Insider Transaction Report
Form 4
O'Brien Ronan
General Counsel & Secretary
Transactions
- Exercise/Conversion
Common Stock
2023-01-14+30,800→ 30,800 total - Exercise/Conversion
Restricted Stock Units
2023-01-14−30,800→ 62,533 total→ Common Stock (30,800 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of PEAR common stock.
- [F2]The remaining restricted stock units shall vest and settle as to 33% of the shares on January 14, 2024 and 34% on January 14, 2025.
Issuer
Pear Therapeutics, Inc.
CIK 0001835567
Entity typeother
Related Parties
1- filerCIK 0001881064
Filing Metadata
- Form type
- 4
- Filed
- Jan 17, 7:00 PM ET
- Accepted
- Jan 18, 5:01 PM ET
- Size
- 6.8 KB